| HOME >> BIOLOGY >> TECHNOLOGY |
Also Announces Preliminary Agreement to Settle Litigation with US Labs
FT. MYERS, Fla., March 18 /PRNewswire-FirstCall/ -- NeoGenomics, Inc.
(OTC Bulletin Board: NGNM) today announced its results for the fourth
quarter and full year of fiscal 2007. Significant accomplishments during
the fourth quarter and calendar year included the following:
Fourth Quarter 2007 Highlights:
-- Revenue of $3.8 million, an increase of 115% year-over-year from Q4 06
-- Avg. Rev/Requisition increased 12.5% in Q4 07 from Q4 06
-- 22% sequential increase in revenues in Q4 07 vs. Q3 07
-- Hiring of additional 7 sales representatives
-- Roll-out of our NeoFLOW(TM) product
-- Almost tripling in size of our Ft. Myers, FL headquarters location
Fiscal Year 2007 Highlights:
-- Revenue of $11.5 million, an increase of 78% from $6.5 million in FY 06
-- Avg. Revenue/Test increased 8.6% in FY 07 from FY 06
-- Received CAP Accreditation for all specialties in all of our laboratory
locations
-- Continued rapid expansion of NeoFISH(TM) tech-only FISH services
Robert Gasparini, the Company's President, stated, "Before discussing
our results, I am happy to report that we have reached a preliminary
agreement to settle US Labs' claims against the Company and certain of its
officers and employees. Under the terms of the agreement, NeoGenomics, on
behalf of all defendants, will make a $250,000 payment to US Labs within
thirty days and pay another $250,000 over the remaining nine months of this
year. We expect that approximately 50% of these payments will be covered by
our insurance policies. As a result, our fourth quarter financials include
a $250,000 charge to cover the Company's expected portion of this
settlement and an additional $125,000 charge to cover the Company's portion
of the estimated legal fees incurred in Q1 up to the date of settlement. We
are pleased to finally put this litigation beh
'/>"/>
| SOURCE NeoGenomics, Inc. Copyright©2008 PR Newswire. All rights reserved |